About Novogene Corporation
Novogene Corporation is a company based in Beijing (China) founded in 2011.. Novogene Corporation has raised $75 million across 3 funding rounds from investors including European Union, SDIC Innovation and CMB International Capital. Novogene Corporation offers products and services including Genome Sequencing, Transcriptome Sequencing, and Epigenome Sequencing. Novogene Corporation operates in a competitive market with competitors including Guardant Health, MedGenome, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter Beijing, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novogene Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$75 M (USD)
in 3 rounds
-
Latest Funding Round
$747.15 K (USD), Grant
Sep 01, 2021
-
Investors
European Union
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novogene Corporation
Novogene Corporation offers a comprehensive portfolio of products and services, including Genome Sequencing, Transcriptome Sequencing, and Epigenome Sequencing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sequences entire genomes for humans, animals, and microbes in research applications.
Analyzes RNA transcripts for gene expression in eukaryotes and prokaryotes.
Examines DNA modifications like methylation for disease and environmental studies.
Unlock access to complete
Funding Insights of Novogene Corporation
Novogene Corporation has successfully raised a total of $75M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $747.15 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $747,152
-
First Round
First Round
(17 Nov 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Grant - Novogene Corporation | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Novogene Corporation | Valuation |
investors |
|
| Nov, 2016 | Amount | Series B - Novogene Corporation | Valuation | SDIC Innovation , CMB International Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novogene Corporation
Novogene Corporation has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SDIC Innovation and CMB International Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm investing in multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novogene Corporation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Novogene Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novogene Corporation Comparisons
Competitors of Novogene Corporation
Novogene Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, MedGenome, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novogene Corporation
Frequently Asked Questions about Novogene Corporation
When was Novogene Corporation founded?
Novogene Corporation was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is Novogene Corporation located?
Novogene Corporation is headquartered in Beijing, China.
Is Novogene Corporation a funded company?
Novogene Corporation is a funded company, having raised a total of $75M across 3 funding rounds to date. The company's 1st funding round was a Series B of $75M, raised on Nov 17, 2016.
What does Novogene Corporation do?
Novogene is a provider of genomic services and solutions with NGS and bioinformatics expertise. Its genomic solutions include whole genome and exome sequencing, RNA sequencing, single cell sequencing, amplicon and metagenomics sequencing, De novo sequencing and pangenome sequencing.It claims to have 34 NGS-related patents and also to be the largest Illumina-based sequencing capacity in China. It offers a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis. Novogenes trademarked NovoPM cancer panel is a comprehensive genetic test that simultaneously sequences the coding region of 483 cancer-related genes and selected introns from 19 genes and is available for both Tissue Biopsy and Liquid Biopsy (ct DNA), and can help physicians in planning therapies based on personalized medicine. The company claims to have applied its NovoPM cancer panel to 3,848 tumor tissue samples and to 2,122 liquid biopsy samples so far. It expanded globally and established Novogene Corporation in the U.S. and Novogene Company Limited in the U.K. in 2014.
Who are the top competitors of Novogene Corporation?
Novogene Corporation's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Novogene Corporation offer?
Novogene Corporation offers Genome Sequencing, Transcriptome Sequencing, and Epigenome Sequencing.
Who are Novogene Corporation's investors?
Novogene Corporation has 4 investors. Key investors include European Union, SDIC Innovation, CMB International Capital, and Sigma Square Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.